Treating Hypertension in Pregnancy

Current Hypertension Reports

Volumn 17, Issue 8, 2015, Pages

  Schlembach, Dietmar ^a   Homuth, Volker ^b   Dechend, Ralf ^b,c  

^a VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^b Experimental and Clinical Research Centre   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Hypertension; Lactation; Medication; Postpartum; Pregnancy; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; FEMALE; HUMAN; HYPERTENSION, PREGNANCY-INDUCED; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREGNANCY; PUERPERIUM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; POSTPARTUM PERIOD; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM;

EID: 84934282369     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-015-0572-y     Document Type: Review

References (58)

1. Seely EW, Ecker J. Clinical practice. Chronic hypertension in pregnancy. N Engl J Med. 2011;365:439–46. Comprehensive review which summarizes the uncertainties when to initiate treatment.
2. American College of O, Gynecologists, Task Force on Hypertension in P. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.
3. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631–44. Outstanding review about pathophysiology and treatment of preeclampsia.
4. Solomon CG, Greene MF. Control of hypertension in pregnancy—if some is good, is more worse? N Engl J Med. 2015;372:475–6. Excellent comment on advantages.
5. Catov JM, Nohr EA, Olsen J, Ness RB. Chronic hypertension related to risk for preterm and term small for gestational age births. Obstet Gynecol. 2008;112:290–6.
6. Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;339:667–71.
7. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case–control study. BMJ. 2001;322:1089–93. discussion 93-4.
8. Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2013;7:CD001449
9. Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY. Preeclampsia: an update. Acta Anaesthesiol Belg. 2014;65:137–49.
10. Wilkinson H, Trustees, Medical A. Saving mothers’ lives. Reviewing maternal deaths to make motherhood safer: 2006–2008. BJOG Int J Obstet Gynaecol. 2011;118:1402–3. discussion 3-4.
11. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–74.
12. Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. London; 2010.
13. Easterling TR. Pharmacological management of hypertension in pregnancy. Semin Perinatol. 2014;38:487–95. Comprehensive and excellent review of treatment choices in pregnancy.
14. Al Khaja KA, Sequeira RP, Alkhaja AK, Damanhori AH. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens. 2014;32:454–63.
15. Too GT, Hill JB. Hypertensive crisis during pregnancy and postpartum period. Semin Perinatol. 2013;37:280–7.
16. Martin Jr JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105:246–54.
17. Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:407–17. Seminal randomized clinical trial which examines two strategies of antihypertensive treatment in pregnancy.
18. Magee LA, Dadelszen P, Rey E, et al. [59-OR]: the control of hypertension in pregnancy study (CHIPS) randomized controlled trial—is the type of antihypertensive important? Pregnancy Hypertens. 2015;5:30–1.
19. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol. 2002;100:369–77.
20. Vest AR, Cho LS. Hypertension in pregnancy. Curr Atheroscler Rep. 2014;16:395.
21. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007;CD002252.
22. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;2:CD002252.
23. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87–92.
24. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG Int J Obstet Gynaecol. 2011;118 Suppl 1:1–203.
25. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.
26. Moser M, Brown CM, Rose CH, Garovic VD. Hypertension in pregnancy: is it time for a new approach to treatment? J Hypertens. 2012;30:1092–100.
27. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008;51:960–9.
28. Cifkova R. Why is the treatment of hypertension in pregnancy still so difficult? Expert Rev Cardiovasc Ther. 2011;9:647–9.
29. Ghanem FA, Movahed A. Use of antihypertensive drugs during pregnancy and lactation. Cardiovasc Ther. 2008;26:38–49. Brilliant summary of the antihyertensive treatment options.
30. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med. 1996;335:257–65.
31. Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol. 1993;168:152–6.
32. Khalil A, Harrington K, Muttukrishna S, Jauniaux E. Effect of antihypertensive therapy with alpha-methyldopa on uterine artery Doppler in pregnancies with hypertensive disorders. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2010;35:688–94.
33. Redman CW, Beilin LJ, Bonnar J. Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects. Br J Obstet Gynaecol. 1977;84:419–26.
34. Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013;20:229–39.
35. Magee LA, Elran E, Bull SB, Logan A, Koren G. Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol. 2000;88:15–26.
36. Waterman EJ, Magee LA, Lim KI, Skoll A, Rurak D, von Dadelszen P. Do commonly used oral antihypertensives alter fetal or neonatal heart rate characteristics? A systematic review. Hypertens Pregnancy. 2004;23:155–69.
37. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2003;CD002863.
38. Sandstrom B. Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Investig. 1978;9:195–204.
39. Oumachigui A, Verghese M, Balachander J. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension. Indian Heart J. 1992;44:39–41.
40. Lunell NO, Fredholm B, Hjemdahl P, et al. Labetalol, a combined alpha- and beta-blocker, in hypertension of pregnancy. Acta Med Scand Suppl. 1982;665:143–7.
41. Tranquilli AL, Giannubilo SR. Use and safety of calcium channel blockers in obstetrics. Curr Med Chem. 2009;16:3330–40.
42. Jayawardana J, Lekamge N. A comparison of nifedipine with methyldopa in pregnancy induced hypertension. Ceylon Med J. 1994;39:87–90.
43. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327:955–60.
44. Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. Br Med J. 1985;290:17–23.
45. Churchill D, Beevers GD, Meher S, Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev. 2007;CD004451.
46. Martinovic J, Benachi A, Laurent N, Daikha-Dahmane F, Gubler MC. Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet. 2001;358:241–2.
47. Lasaitiene D, Chen Y, Adams MA, Friberg P. Further insights into the role of angiotensin II in kidney development. Clin Physiol Funct Imaging. 2006;26:197–204.
48. Vadhera RB, Simon M. Hypertensive emergencies in pregnancy. Clin Obstet Gynecol. 2014;57:797–805.
49. Committee on Obstetric P. Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet Gynecol. 2011;118:1465–8.
50. Wacker JR, Wagner BK, Briese V, et al. Antihypertensive therapy in patients with pre-eclampsia: a prospective randomised multicentre study comparing dihydralazine with urapidil. Eur J Obstet Gynecol Reprod Biol. 2006;127:160–5.
51. Magee LA, Abalos E, von Dadelszen P, et al. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol. 2011;72:394–401.
52. McClure CK, Catov JM, Ness RB, Schwarz EB. Lactation and maternal subclinical cardiovascular disease among premenopausal women. Am J Obstet Gynecol. 2012;207:46 e1-8.
53. Stuebe AM, Schwarz EB, Grewen K, et al. Duration of lactation and incidence of maternal hypertension: a longitudinal cohort study. Am J Epidemiol. 2011;174:1147–58.
54. Beardmore KS, Morris JM, Gallery ED. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy. 2002;21:85–95.
55. Magee L, von Dadelszen P. Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev. 2013;4:CD004351.
56. Shannon ME, Malecha SE, Cha AJ. Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) and lactation: an update. J Human Lact Off J Int Lact Consult Assoc. 2000;16:152–5.
57. American Academy of Pediatrics Committee on D. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776–89.
58. Bramham K, Nelson-Piercy C, Brown MJ, Chappell LC. Postpartum management of hypertension. BMJ. 2013;346:f894. Comprehensive review of antihypertensive management postpartum.